-+ 0.00%
-+ 0.00%
-+ 0.00%

INNOCARE PHARMA - SOFICITINIB SHOWS FAVORABLE SAFETY PROFILE WITH NO NEW SAFETY SIGNALS IN PHASE II TRIAL

路透·07/16/2026 13:00:02

登录查看新闻详情